Patent: (prefix with "US" like US6078908)

 2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012

  1. Patent
    Data
    Cmpds
    UniProt
    HGNC*
    Patent Title
    Organization
    Deposition
    Downloads
  2. US12643887-B2
    552
    99
    Q86Z02 P49841 Q13627 P19784 P49759 Q9H2X6 O14578 Q6FI27
    HGNC:4617 2459 3091 19006
    Heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases
    Tongji University
    10/19/26
    2D 3D TSV
  3. US12643889-B2
    30
    15
    P35408
    HGNC:9596
    Synthesis of novel EP4 antagonist and use in cancer and inflammation
    Wuhan Humanwell Innovative Drug Research And Development Center
    10/19/26
    2D 3D TSV
  4. US12643890-B2
    21
    21
    Q13822
    HGNC:3357
    Substituted amino-pyrimidines
    Hoffmann-La Roche
    10/19/26
    2D 3D TSV
  5. US12643910-B2
    259
    259
    P22413
    HGNC:3356
    Substituted pyrazolo[3,4-b]pyridines as ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) modulators
    Sanford Burnham Prebys Medical Discovery Institute
    10/19/26
    2D 3D TSV
  6. US12643912-B2
    101
    101
    Q14145
    HGNC:23177
    Macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
    Les Laboratoires Servier
    10/19/26
    2D 3D TSV
  7. US20260146035-A1
    549
    183
    Q12866 P14679 P30530
    HGNC:12442 905 7027
    FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS
    Dong-A St Co.
    10/14/26
    2D 3D TSV
  8. US20260146050-A1
    67
    61
    Q96SW2 L7RSL8 Q07889 Q16531 P01116
    HGNC:5981 2717 11187
    KRAS DEGRADING COMPOUNDS COMPRISING SPIROCYCLIC ANNULATED 2 AMINO-3-CYANO THIOPHENES
    Boehringer Ingelheim International
    10/14/26
    2D 3D TSV
  9. US12637430-A1
    49
    47
    Q16552
    HGNC:5981
    Interleukin-17 (IL-17) inhibitors
    HitGen
    10/13/26
    2D 3D TSV
  10. US12636275-B2
    38
    37
    P07711 P0DTC1
    HGNC:2537
    Pharmaceutical use of ketoamide-based compound
    Shanghai Institute of Materia Medica, Chinese Academy Of Sciences
    10/12/26
    2D 3D TSV
  11. US12637428-B2
    721
    138
    P00519 P57059 P12931 Q9H0K1 P29317 Q9Y2K2
    HGNC:3386 11283 76 29165 21680 11142
    Isoquinoline derivatives as SIK2 inhibitors
    Cancer Research Technology
    10/12/26
    2D 3D TSV
  12. US12637440-B2
    130
    128
    Q96PD7
    HGNC:16940
    Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof
    LG Chem
    10/12/26
    2D 3D TSV
  13. US12637454-B2
    72
    72
    Q99685
    HGNC:17038
    Heterocyclic monoacylglycerol lipase (MAGL) inhibitors
    Hoffmann-La Roche
    10/12/26
    2D 3D TSV
  14. US12637455-B2
    45
    44
    P31644
    HGNC:4079
    Naphthyridine and pyrido[3,4-c]pyridazine derivatives as GABAA α5 receptor modulators
    Richter Gedeon
    10/12/26
    2D 3D TSV
  15. US12637469-B2
    90
    10
    P36507 P07947 P10635 P28482 P07949 P07948 P11802 P97820 P12931 O75582 Q06187 Q08881 P21802 P42345 P15056 Q06418 P61024 P17948 P08684 P49137 P05177 P52564 P35968 P08922 Q6GRK0 P36897 A0A024R7M7 P10721 Q5T7S2 P53778 P53779 P16234 P20248 Q02763 P30281 P00533 O14757 P52333 P06239 P29597 Q15759 O15264 P36888 Q05397 P61160 Q00534 P33261 P06241 P42681 O14920 O95819 Q16539 O15111 P11712 P49674 P04626 P31749 O75116 Q8WUW1 P04629 Q02750 C1ID52 P17612 P11362 P43405 P00519 O60674 P22607 P24941 P45983 P23458 Q96GD4 P45984 P08631 P06213 P62942
    HGNC:10252 12434 2596 391 3763 2637 6871 6872 3689 6873 6874 6875 3688 3765 6876 6190 9380 6192 6193 11390 10261 12440 12841 12446 6866 8803 4840 3430 6307 1133 1771 1097 19083 6342 1777 9611 169 2625 3711 2623 1773 3236 1974 2621 1925 11283 2453 11724 10434 6735 4037 5960 3942 9967 6091 6171 11491 8031 11772 6846 76 3690 6881 6840 6886 6842 6524 6887
    1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2
    Ocumension Therapeutics (Suzhou) Co.
    10/12/26
    2D 3D TSV
  16. US20260137669-A1
    9
    9
    P00918
    HGNC:1373
    NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS
    Innovative Molecules
    09/30/26
    2D 3D TSV
  17. US20260137698-A1
    285
    83
    P20248 P50750 Q14004 P51948 P24941 P50613 P51946 O75909
    HGNC:7181 1780 1771
    CYCLIN-DEPENDENT KINASE 7 INHIBITORS
    Joint Stock Company «Biocad»
    09/30/26
    2D 3D TSV
  18. US20260137699-A1
    140
    67
    L7RSL8 Q07889 P01116
    HGNC:5981
    OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF
    Genentech
    09/30/26
    2D 3D TSV
  19. US20260138959-A1
    103
    69
    P16234 P09619 P10721
    HGNC:8803 8804 6342
    QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF
    Voronoi
    09/30/26
    2D 3D TSV
  20. US20260138961-A1
    20
    20
    P54098
    HGNC:9179
    MODULATORS OF MITOCHONDRIAL DNA REPLICATION
    Pretzel Therapeutics
    09/30/26
    2D 3D TSV
  21. US20260138982-A1
    29
    29
    P42336
    HGNC:8975
    Biaryl Acid Compounds
    Pfizer
    09/30/26
    2D 3D TSV
  22. US20260138986-A1
    85
    22
    P16234 P10635 P11712 Q6GRK0 P08684 P10721 C1ID52
    HGNC:8803 2637 6342 2625 2623
    PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES
    Blueprint Medicines
    09/30/26
    2D 3D TSV
  23. US12630528-B2
    179
    179
    Q96PD7
    HGNC:16940
    Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof
    LG Chem
    09/29/26
    2D 3D TSV
  24. US12629358-B2
    18
    18
    P07949
    HGNC:9967
    Compound used as RET kinase inhibitor and application thereof
    Tyk Medicines
    09/28/26
    2D 3D TSV
  25. US12630497-B2
    110
    55
    P40926 P40925
    HGNC:6970 6971
    Compound having malate dehydrogenase inhibitory activity and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient
    Dongguk University Industry-Academic Cooperation Foundation
    09/28/26
    2D 3D TSV
  26. US12630511-B2
    13
    13
    P00533
    HGNC:3236
    Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer
    Korea Research Institute of Chemical Technology
    09/28/26
    2D 3D TSV
  27. US12630561-B2
    88
    22
    O00329 P48736 P42338 P42336
    HGNC:8978 8975 8977 8976
    Tricyclic derivatives inhibitor, preparation method, and applications thereof
    Jiangsu Hansoh Pharmaceutical Group Co.
    09/28/26
    2D 3D TSV
  28. US12630565-B2
    90
    90
    P78527
    HGNC:9413
    DNA-dependent protein kinase inhibitor
    Dizal (Jiangsu) Pharmaceutical Co.
    09/28/26
    2D 3D TSV
  29. US20260132122-A1
    212
    106
    P24385 P11802 P24941 P24864
    HGNC:1771 1773
    6-6-FUSED BICYCLIC HETEROARYL AMINES AS CDK4 INHIBITORS
    Incyte
    09/23/26
    2D 3D TSV
  30. US20260132127-A1
    442
    442
    Q9UKU6
    NOVEL SPIRO COMPOUND
    Mitsubishi Tanabe Pharma
    09/23/26
    2D 3D TSV
  31. US20260132132-A1
    995
    514
    P03951 P03952 P00747 P00748 P00734 P06870 P00742 P07477
    HGNC:3530 6371 9475 3528 3529 3535 6357 9071
    3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS
    Kalvista Pharmaceuticals
    09/23/26
    2D 3D TSV
  32. US20260132136-A1
    768
    167
    Q9HBY0 Q9NPH5 P04839 Q9Y5S8 Q96PH1
    HGNC:7889 7890 7891 2578 14874
    Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4
    Boehringer Ingelheim International
    09/23/26
    2D 3D TSV
  33. US20260132140-A1
    413
    190
    Q15349 O96017 Q15418 P51812 Q9UK32 O14757
    HGNC:10435 1925 16627 10431 10430 10432
    IMIDAZOLYL-AMINO-PYRAZINE-CARBONITRILS AS CHK-1 INHIBITORS
    Benevolentai Bio
    09/23/26
    2D 3D TSV
  34. US20260132158-A1
    71
    47
    Q04912 P08581
    HGNC:7381 7029
    PHENYL OXY AMIDE KINASE INHIBITORS
    The Translational Genomics Research Institute
    09/23/26
    2D 3D TSV
  35. US12624018-B1
    811
    621
    O43353 Q9HC29
    HGNC:5331 10020
    Inhibitors of RIPK2 and medical uses thereof
    Odyssey Therapeutics
    09/21/26
    2D 3D TSV
  36. US12624022-B2
    13
    13
    Q15116 Q9NZQ7
    HGNC:8760
    Heterocyclic immunomodulators as PDL1 checkpoint inhibitor
    Janssen Sciences Ireland
    09/21/26
    2D 3D TSV
  37. US12624028-B2
    152
    152
    P01009 P08246
    HGNC:990
    1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
    Vertex Pharmaceuticals
    09/21/26
    2D 3D TSV
  38. US12624050-B2
    68
    17
    O00329 P48736 P42338 P42336
    HGNC:8978 8975 8977 8976
    Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof
    Shanghai Hansoh Biomedical
    09/21/26
    2D 3D TSV
  39. US20260125375-A1
    590
    295
    Q9ULV8 Q13191
    HGNC:1542
    SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS
    Pfizer
    09/17/26
    2D 3D TSV
  40. US20260125379-A1
    48
    24
    O60674 P23458
    HGNC:6190 6192
    PRODRUG OF JAK KINASE INHIBITOR
    E-Nitiate Biopharmaceuticals (Hangzhou)
    09/17/26
    2D 3D TSV
  41. US20260125380-A1
    8
    8
    A0A090N8Q0 Q12809
    HGNC:6251
    PRMT5 INHIBITORS AND METHODS OF USE
    Shanghai Apeiron Therapeutics
    09/17/26
    2D 3D TSV
  42. US20260125383-A1
    87
    73
    Q8N884
    HGNC:21367
    INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF
    Ventus Therapeutics U.S.
    09/17/26
    2D 3D TSV
  43. US20260125384-A1
    100
    99
    Q8N884
    HGNC:21367
    INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF
    Ventus Therapeutics U.S.
    09/17/26
    2D 3D TSV
  44. US20260125391-A1
    238
    238
    P24385 P11802
    HGNC:1773
    PYRIMIDINE INDOLES AS CDK4 INHIBITORS
    Incyte
    09/17/26
    2D 3D TSV
  45. US20260125399-A1
    79
    79
    P0DTC1
    Substituted Pyrazolo[3,4-b]pyridine Compounds and Methods of Use Thereof
    Rutgers, The State University Of New Jersey
    09/17/26
    2D 3D TSV
  46. US20260124192-A1
    12
    12
    P0C6U2
    COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS
    Model Medicines
    09/16/26
    2D 3D TSV
  47. US20260124222-A1
    177
    177
    Q9UDY8
    HGNC:6819
    ISOTHIAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY
    Hotspot Therapeutics
    09/16/26
    2D 3D TSV
  48. US20260125365-A1
    945
    894
    P0DTC1
    TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Shionogi
    09/16/26
    2D 3D TSV
  49. US20260125370-A1
    184
    92
    Q13547 Q9UBN7
    HGNC:4852 14064
    SULFOXIMINE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Chong Kun Dang Pharmaceutical
    09/16/26
    2D 3D TSV
  50. US20260125372-A1
    54
    54
    O00429 Q96C03
    HGNC:23177
    DYNAMIN-1-LIKE PROTEIN INHIBITORS AND USES THEREOF
    Astellas Engineered Small Molecules US
    09/16/26
    2D 3D TSV
  51. US12617759-B2
    38
    19
    P28223 P35462
    HGNC:3024 5293
    Modifier of four-membered ring derivative, preparation method and application thereof
    Shanghai Hansoh Biomedical
    09/14/26
    2D 3D TSV
  52. US12617770-B2
    41
    25
    P10635 P11712 P51617 Q6GRK0 P33261 P08684 Q9NWZ3 P05177 C1ID52
    HGNC:2596 2637 6112 2625 17967 2623 2621
    IRAK inhibitor and preparation method therefor and use thereof
    Wuhan Createrna Science and Technology
    09/14/26
    2D 3D TSV
  53. US12617772-B2
    7
    7
    Q7Z5P4
    HGNC:18685
    Hydroxypyridine HSD17B13 inhibitors and uses thereof
    Inipharm
    09/14/26
    2D 3D TSV
  54. US12617784-B2
    159
    53
    Q9Y243 P31749 P31751
    HGNC:391 392 393
    AKT inhibitor
    Nanjing Chia Tai Tianqing Pharmaceutical
    09/14/26
    2D 3D TSV
  55. US12617785-B2
    78
    69
    O95835
    HGNC:6514
    Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss
    The Rockefeller University
    09/14/26
    2D 3D TSV
  56. US20260116867-A1
    13
    13
    Q96SW2
    HGNC:30185
    PROTEOLYSIS TARGETING CHIMERAS FOR HUMAN PREGNANE X RECEPTOR AND FOR DEGRADATION OF GSPT1
    ST. JUDE CHILDREN''S RESEARCH HOSPITAL
    09/09/26
    2D 3D TSV
  57. US20260116881-A1
    664
    664
    Q8NI77
    HGNC:29441
    KIF MODULATOR COMPOUNDS AND METHODS OF USE
    Iambic Therapeutics
    09/09/26
    2D 3D TSV
  58. US20260116884-A1
    40
    40
    Q92918
    HGNC:6863
    PROTAC CHIMERIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    Hangzhou Zhongmeihuadong Pharmaceutical Co.
    09/09/26
    2D 3D TSV
  59. US20260116887-A1
    200
    100
    P29597 O60674
    HGNC:6192 12440
    HETEROCYCLIC COMPOUNDS FOR MEDIATING TYROSINE KINASE 2 ACTIVITY
    Guangzhou Innocare Pharma Tech Co.
    09/09/26
    2D 3D TSV
  60. US20260116889-A1
    94
    45
    Q5S007
    HGNC:18618
    MACROCYCLIC PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE CONTAINING SAME AS ACTIVE INGREDIENT
    Whan In Pharmaceutical Co.
    09/09/26
    2D 3D TSV
  61. US12612408-B2
    30
    30
    P30291
    HGNC:12761
    Pyrazolone-fused pyrimidine compound, preparation method for same and applications thereof
    Shanghai Pharmaceuticals Holding Co.
    09/08/26
    2D 3D TSV
  62. US20260109699-A1
    84
    84
    Q06124
    HGNC:9644
    AZOLE DERIVATIVES AS SHP2 INHIBITORS
    IRBM
    09/03/26
    2D 3D TSV
  63. US20260109708-A1
    55
    55
    P36507
    HGNC:6842
    COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE
    Celgene
    09/03/26
    2D 3D TSV
  64. US20260109709-A1
    304
    140
    O14744 Q9BQA1
    HGNC:29652
    2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS
    Mirati Therapeutics
    09/03/26
    2D 3D TSV
  65. US20260109729-A1
    46
    10
    P17931 P09382
    HGNC:6561 6563
    RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF
    Academy of Sciences of the Czech Republic
    09/03/26
    2D 3D TSV
  66. US20260108494-A1
    208
    70
    P31645 P28335 P28223 A0A024R3C5 P14416
    HGNC:3023 11050 5295 5293
    THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
    Neuroinnovatech
    09/02/26
    2D 3D TSV
  67. US20260108512-A1
    21
    21
    P06239 Q13191
    HGNC:3467
    COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
    Hotspot Therapeutics
    09/02/26
    2D 3D TSV
  68. US20260108613-A1
    21
    21
    P40337
    HGNC:12687
    Compounds and Compositions as VHL Ligands and STAT3 Degraders Uses Thereof
    University of Michigan
    09/02/26
    2D 3D TSV
  69. US20260109672-A1
    41
    41
    P0DTC1
    SARS-COV-2 MPRO INHIBITORS AND USES THEREOF
    Nxera Pharma
    09/02/26
    2D 3D TSV
  70. US20260109684-A1
    11
    11
    Q15109
    HGNC:320
    QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF
    New York University
    09/02/26
    2D 3D TSV
  71. US20260109686-A1
    226
    147
    A0A024R3T8 Q7Z3E1 Q9UGN5 Q9H0J9 Q9H2K2 Q9UKK3 Q460N5 O95271 Q9NR21 Q460N3 Q8N3A8 Q9Y6F1 Q53GL7 Q8N5Y8 Q2NL67 P09874
    HGNC:15677 21919 29232 26040 270 1186 11941 271 272 25895 26124 26921 273 23696 26876
    PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS
    Azkarra Therapeutics
    09/02/26
    2D 3D TSV
  72. US20260109690-A1
    37
    37
    Q9UBN7
    HGNC:14064
    HDAC6 INHIBITORS AND METHOD OF THEIR USE
    Baerenkraft Therapeutics
    09/02/26
    2D 3D TSV
  73. US20260109697-A1
    269
    269

    4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES
    Merck Patent
    09/02/26
    2D 3D TSV
  74. US12605353-B2
    65
    65
    P13667
    HGNC:30167
    PDIA4 inhibitors and use thereof for inhibiting β-cell pathogenesis and treating diabetes
    Academia Sinica
    08/31/26
    2D 3D TSV
  75. US12605369-B2
    36
    23
    Q997M8 Q6TFM6
    Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses
    Merck Sharp & Dohme
    08/31/26
    2D 3D TSV
  76. US12605375-B2
    2
    2
    P07333
    HGNC:2433
    Use of CSF-1R kinase inhibitor
    Shanghai Runshi Medical Technology Co.
    08/31/26
    2D 3D TSV
  77. US12606540-B2
    21
    21
    Q02127
    HGNC:2867
    Triazolone compound
    Medshine Discovery
    08/31/26
    2D 3D TSV
  78. US12606544-B2
    232
    58
    P52333 P29597 O60674 A0A024R7M7 P23458
    HGNC:6190 6192 6193 12440
    JAK1 selective kinase inhibitor
    Dizal (Jiangsu) Pharmaceutical Co.
    08/31/26
    2D 3D TSV
  79. US12606554-B2
    18
    6
    P57059 Q9H0K1 Q9Y2K2
    HGNC:29165 21680 11142
    Compounds and pharmaceutical compositions thereof for the treatment of diseases
    Onco3R Therapeutics
    08/31/26
    2D 3D TSV
  80. US12606564-B2
    103
    56
    P29274 P30542
    HGNC:262 263
    Adenosine receptor antagonist compounds
    Ildong Pharmaceutical Co.
    08/31/26
    2D 3D TSV
  81. US12606566-B2
    27
    27
    Q06187
    HGNC:1133
    Substituted cyclopenta[4,5]pyrrolo[1,2-a]pyrazines as bruton's tyrosine kinase inhibitors
    Shanghai Synergy Pharmaceutical Sciences Co.
    08/31/26
    2D 3D TSV
  82. US20260102395-A1
    106
    76
    Q9BY41 Q9UBN7
    HGNC:14064 13315
    INHIBITING HISTONE DEACETYLASE 6
    Eikonizo Therapeutics
    08/26/26
    2D 3D TSV
  83. US20260103453-A1
    23
    23
    Q06187
    HGNC:1133
    NOVEL PYRIMIDINE DERIVATIVE AS BRUTON'S TYROSINE KINASE INHIBITOR
    Hanmi Pharm. Co.
    08/26/26
    2D 3D TSV
  84. US20260103468-A1
    2
    2
    Q96SW2
    HGNC:30185
    FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
    Hainan Simcere Zaiming Pharmaceutical Co.
    08/26/26
    2D 3D TSV
  85. US20260103474-A1
    20
    20
    Q13148
    HGNC:11571
    NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES
    AC Immune
    08/26/26
    2D 3D TSV
  86. US12599616-B2
    15
    15
    P01584
    HGNC:5992
    Subtituted sulfonylurea and sulfoximineurea derivatives
    Zydus Lifesciences
    08/24/26
    2D 3D TSV
  87. US12599676-B2
    10
    10
    P30419
    HGNC:7857
    Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy
    Myricx Pharma
    08/24/26
    2D 3D TSV
  88. US12600712-B2
    16
    16
    Q13822
    HGNC:3357
    Amino-pyrimidine amides
    Hoffmann-La Roche
    08/24/26
    2D 3D TSV
  89. US12600714-B2
    20
    20
    P00533
    HGNC:3236
    Substituted pyrazinecarboxamide compounds for treating diseases related to EGFR mutation
    Wigen Biomedicine Technology (Shanghai) Co.
    08/24/26
    2D 3D TSV
  90. US12600731-B2
    106
    44
    P20248 Q00534 P30281 P11802 P24941
    HGNC:1771 1777 1773
    Isoxazolo[5,4-H]quinazoline compounds as protein kinase inhibitors
    Chengdu Cynogen Bio-Pharmaceutical Technology Co.
    08/24/26
    2D 3D TSV
  91. US20260098025-A1
    17
    17
    P13807
    HGNC:4706
    DIMERIC COMPOUNDS AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
    Maze Therapeutics
    08/19/26
    2D 3D TSV
  92. US20260098038-A1
    411
    409
    Q13724
    HGNC:24862
    NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
    Yuhan
    08/19/26
    2D 3D TSV
  93. US20260098039-A1
    1
    1
    Q7Z3E1
    HGNC:23696
    SOLID FORMS OF COMPOUND I OR SALTS THEREOF
    Jacobio Pharmaceuticals
    08/19/26
    2D 3D TSV
  94. US20260098043-A1
    2
    2
    Q96SW2
    HGNC:30185
    POLYCYCLIC COMPOUND AND USE THEREOF
    Hainan Simcere Zaiming Pharmeceutical
    08/19/26
    2D 3D TSV
  95. US20260098044-A1
    58
    29
    P29597 P23458
    HGNC:6190 12440
    TRICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF TYK2 AND/OR JAK1
    Incyte
    08/19/26
    2D 3D TSV
  96. US20260098060-A1
    53
    53
    Q6GRK0 P08684
    HGNC:2637
    MACROCYCLIC CFTR MODULATORS
    Idorsia Pharmaceuticals
    08/19/26
    2D 3D TSV
  97. US12594261-B2
    15
    5
    P49841 Q13627 P49759 Q6FI27
    HGNC:4617 3091
    Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases
    Shanghai East Hospital
    08/17/26
    2D 3D TSV
  98. US12594277-B2
    25
    25
    O75385
    HGNC:12558
    Macrocyclic ULK1/2 inhibitors
    Salk Institute
    08/17/26
    2D 3D TSV
  99. US12595236-B2
    39
    38
    P53634
    HGNC:2528
    Pyrimidine-2,4-diamine compound and preparation method and application thereof
    Anhui Medical University
    08/17/26
    2D 3D TSV
  100. US12595267-B2
    128
    32
    Q15910 Q15022 O75530
    HGNC:17101 1503 13575 6524
    Preparation method for amide compound and application thereof in field of medicine
    Shanghai Synergy Pharmaceutical Sciences
    08/17/26
    2D 3D TSV
  101. US20260091026-A1
    237
    194
    O43353 P98170
    HGNC:10020 17635
    METHODS OF TREATING INFLAMMATORY DISEASES
    Interline Therapeutics
    08/12/26
    2D 3D TSV
  102. US20260092039-A1
    54
    29
    Q16769 P34913
    HGNC:9753 3402
    DUAL INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Universitat De Barcelona
    08/12/26
    2D 3D TSV
  103. US20260092055-A1
    57
    57
    Q02H34
    Aromatic Acetylene Derivative, Preparation Method Therefor, And Pharmaceutical Use Thereof
    Zhejiang Hisun Pharmaceutical Co.
    08/12/26
    2D 3D TSV
  104. US20260092074-A1
    742
    371
    P19099 P15538
    HGNC:2592 2591
    Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof
    Guangzhou Vinnocent Pharmaceutical
    08/12/26
    2D 3D TSV
  105. US12590070-B2
    58
    30
    Q14289 Q05397 P06213
    HGNC:6091 9611 9612
    Adamantane derivatives as inhibitors of focal adhesion kinase
    Samjin Pharmaceutical Co.
    08/10/26
    2D 3D TSV
  106. US12590087-B2
    35
    35
    Q9P275
    HGNC:20062
    Inhibiting USP36
    Valo Health
    08/10/26
    2D 3D TSV
  107. US12590092-B2
    18
    6
    P43490 J7EJG0 P16071
    HGNC:30092
    Antiviral agents and uses thereof
    Griffith University
    08/10/26
    2D 3D TSV
  108. US12590118-B2
    41
    41
    P62813
    Salt and crystal form of steroid derivative regulator
    Shanghai Hansoh Biomedical
    08/10/26
    2D 3D TSV
  109. US20260083851-A1
    394
    393
    P07306
    HGNC:742
    POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS
    Avilar Therapeutics
    08/05/26
    2D 3D TSV
  110. US20260085034-A1
    113
    73
    Q86WU2 P54840 P30613 P13807
    HGNC:30024 1133
    N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
    Maze Therapeutics
    08/05/26
    2D 3D TSV
  111. US20260085046-A1
    56
    56
    Q13547
    HGNC:4852
    Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition
    Taiwanj Pharmaceuticals Co.
    08/05/26
    2D 3D TSV
  112. US20260085050-A1
    27
    17
    P08581 P00533 Q9UM73
    HGNC:427 3236 7029
    TRIPLE KINASE INHIBITORS
    Unogen Biotech
    08/05/26
    2D 3D TSV
  113. US20260085053-A1
    405
    135
    P57059 Q9H0K1 Q9Y2K2
    HGNC:21680 11142
    BENZOFURAN DERIVATIVES AS SIK INHIBITORS AND THE USE THEREOF
    Beone Medicines I
    08/05/26
    2D 3D TSV
  114. US20260085062-A1
    416
    208
    P68400 P49760
    HGNC:2069 2457
    NOVEL COMPOUNDS AS CK2 INHIBITORS
    Cambridge Enterprise
    08/05/26
    2D 3D TSV
  115. US20260085063-A1
    88
    88
    P0DTC1
    BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF
    The State University of New Jersey
    08/05/26
    2D 3D TSV
  116. US20260085069-A1
    2
    1
    P68400 P49760
    HGNC:2069 2457
    PRODRUGS
    Cambridge Enterprise
    08/05/26
    2D 3D TSV
  117. US20260085070-A1
    4
    4
    P22681
    HGNC:1541
    HETEROCYCLIC CBL-B INHIBITORS FOR THE TREATMENT OF CANCER
    Hotspot Therapeutics
    08/05/26
    2D 3D TSV
  118. US20260085073-A1
    262
    262
    Q9UDY8
    HGNC:6819
    PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY
    Hotspot Therapeutics
    08/05/26
    2D 3D TSV
  119. US20260085076-A1
    2
    2
    P52333 A0A024R7M7
    HGNC:6193
    CRYSTAL FORM OF AROMATIC HETEROCYCLIC COMPOUND, COMPOSITION THEREOF, PRODUCTION METHOD THEREOF AND USES THEREOF
    Hangzhou Yuhong Pharmaceutical Technology Co.
    08/05/26
    2D 3D TSV
  120. US12582650-B2
    21
    21
    Q9NWZ3
    HGNC:17967
    IRAK4 kinase inhibitor and preparation method therefor
    Guangzhou Yufan Nantu Biotechnologies Co.
    08/03/26
    2D 3D TSV
  121. US12582653-B2
    10
    10
    O75116
    HGNC:10252
    Method for treating idiopathic pulmonary fibrosis
    Beijing Tide Pharmaceutical Co.
    08/03/26
    2D 3D TSV
  122. US12582654-B2
    163
    84
    P22455
    HGNC:3691
    Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereof
    Beijing Scitech-MQ Pharmaceuticals
    08/03/26
    2D 3D TSV
  123. US12582655-B2
    8
    2
    P16234 P10721 P07333 P36888
    HGNC:8803 6342 2433 3765
    Methods of treating disorders using CSFIR inhibitors
    Deciphera Pharmaceuticals
    08/03/26
    2D 3D TSV
  124. US12583820-B2
    124
    71
    A0A1L2E0X0 P0C6X7 P0DTC1
    Broad spectrum antivirals against coronavirus
    Kansas State University Research Foundation; Wichita State University; University of Iowa Research Foundation
    08/03/26
    2D 3D TSV
  125. US12583825-B2
    116
    116
    P49761
    HGNC:2071
    Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer
    Redona Therapeutics
    08/03/26
    2D 3D TSV
  126. US12583836-B2
    952
    319
    Q8NB16 A0A024QZU0 Q13546 Q9Y572
    HGNC:26617 10019 10021
    Sulphonamide compounds
    Anaxis Pharma
    08/03/26
    2D 3D TSV
  127. US12583841-B2
    26
    13
    O43614 O43613
    HGNC:4849 4848
    Tetrahydropyrrolocyclic compound and application thereof
    Breakthrough Pharmaceuticals
    08/03/26
    2D 3D TSV
  128. US12583853-B2
    5
    5
    P10415
    HGNC:990
    1H-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases
    Newave Pharmaceutical
    08/03/26
    2D 3D TSV
  129. US12583855-B2
    189
    77
    P35968 P07949
    HGNC:6307 9967
    RET selective inhibitor, preparation method therefor and use thereof
    Shouyao Holdings (Beijing) Co.
    08/03/26
    2D 3D TSV
  130. US12583856-B2
    94
    94
    P17612
    HGNC:9380
    Inhibitors of protein kinase A
    Blueprint Medicines
    08/03/26
    2D 3D TSV
  131. US20260076975-A1
    62
    62
    Q9H3S4
    HGNC:17358
    TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES
    Shanghai Raising Pharmaceutical Co.
    07/29/26
    2D 3D TSV
  132. US20260078095-A1
    19
    19
    P30989
    HGNC:8039
    NEUROTENSIN RECEPTOR LIGANDS
    3B Pharmaceuticals
    07/29/26
    2D 3D TSV
  133. US20260078114-A1
    146
    73
    P24385 Q00534 P30281 P11802
    HGNC:1777 1773
    COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF
    Tyk Medicines
    07/29/26
    2D 3D TSV
  134. US20260078121-A1
    13
    9
    Q03111 P36888
    HGNC:7134 3765
    INHIBITORS OF ENL/AF9 YEATS AND FLT3
    Bridge Medicines
    07/29/26
    2D 3D TSV
  135. US20260078122-A1
    186
    186
    Q99640
    HGNC:29650
    INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS
    Hoffmann-La Roche
    07/29/26
    2D 3D TSV
  136. US20260078123-A1
    3
    3
    P07949
    HGNC:9967
    PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF
    Shanghai Daidai Investment Consulting Co.
    07/29/26
    2D 3D TSV
  137. US20260078129-A1
    19
    19
    P23458
    HGNC:6190
    JAK INHIBITOR AND PREPARATION METHOD THEREFOR
    Felicamed Biotechnology Co.
    07/29/26
    2D 3D TSV
  138. US20260078130-A1
    648
    648
    P43490
    HGNC:30092
    NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF
    Sironax
    07/29/26
    2D 3D TSV
  139. US12577217-B2
    616
    616
    P15428
    HGNC:5154
    15-PGDH inhibitor
    Kyorin Pharmaceutical Co.
    07/27/26
    2D 3D TSV
  140. US12577230-B2
    30
    21
    P36897 Q5T7S2
    HGNC:11772
    2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)- acetamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5
    Agomab Spain S.L.U.
    07/27/26
    2D 3D TSV
  141. US12577235-B2
    1
    1
    P25025
    HGNC:6027
    Crystalline form of CXCR2 antagonist and application thereof
    Shenzhen Optimum Biological Technology Co.
    07/27/26
    2D 3D TSV
  142. US12577248-B2
    77
    77
    P43405
    HGNC:11491
    Substituted [1,2,4]triazolo[1,5-a]pyrazines as spleen tyrosine kinase inhibitors
    Nanjing Ruijie Pharma Co.
    07/27/26
    2D 3D TSV
  143. US12581252-B2
    2689
    2689
    P42336
    HGNC:8975
    Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors
    Relay Therapeutics
    07/27/26
    2D 3D TSV
  144. US20260070924-A1
    75
    14
    P11309 Q86V86 Q9HAZ1 P49761 P49760 Q9P1W9 P49759 P36888
    HGNC:2068 13659 2069 19310 2071 8986 3765 8987
    INDAZOLE MACROCYCLES AND THEIR USE
    Blossomhill Therapeutics
    07/23/26
    2D 3D TSV
  145. US20260070927-A1
    52
    47
    A0A090N8Q0 Q12809 Q86WV6
    HGNC:6251 27962
    INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE
    Hoffmann-La Roche
    07/23/26
    2D 3D TSV
  146. US20260069571-A1
    189
    95
    A0A024RCL1 Q16832 Q08345
    HGNC:2730 2731
    DDR1 AND DDR2 INHIBITORS FOR THE TREATEMENT OF CANCER AND FIBROTIC DISEASES
    Redx Pharma
    07/22/26
    2D 3D TSV
  147. US20260070878-A1
    176
    88
    Q9H2K2 O95271
    HGNC:11941 15677
    TNKS2 INHIBITORS
    Cornell University
    07/22/26
    2D 3D TSV
  148. US20260070885-A1
    6
    2
    P04629 P36888
    HGNC:8031 3765
    TRKA (G667C) AND FLT3 TARGET INHIBITOR AND COMBINATION OF SAME WITH CHIDAMIDE
    Shenzhen Chipscreen Biosciences
    07/22/26
    2D 3D TSV
  149. US20260070887-A1
    135
    135
    Q8NI77
    HGNC:29441
    AMIDE OR UREA COMPOUND
    Shenzhen Zhongge Biological Technology
    07/22/26
    2D 3D TSV
  150. US20260070888-A1
    10
    10
    O00411
    HGNC:9200
    7-ALKOXYQUINOLINES AS MODULATORS OF POLRMT
    Pretzel Therapeutics
    07/22/26
    2D 3D TSV
  151. US20260070901-A1
    348
    174
    P68400 P49760
    HGNC:2069 2457
    NOVEL COMPOUNDS AS CK2 INHIBITORS
    Cambridge Enterprise
    07/22/26
    2D 3D TSV
  152. US20260070914-A1
    434
    217
    P24385 P11802 P24941 P24864
    HGNC:1771 1773
    SUBSTITUTED PYRROLO[2,1-F][1,2,4]TRIAZIN-2-AMINES AS CDK2 AND CDK4 INHIBITORS
    Incyte
    07/22/26
    2D 3D TSV
  153. US20260070915-A1
    88
    44
    P24385 P11802 P24941 P24864
    HGNC:1771 1773
    SUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINES AS SELECTIVE CDK2/4 INHIBITORS
    Incyte
    07/22/26
    2D 3D TSV
  154. US20260070918-A1
    11
    11
    P35408
    HGNC:9596
    HETEROBICYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS
    Shenzhen Ionova Life Science
    07/22/26
    2D 3D TSV
  155. US12570648-B2
    35
    35
    Q07817 P08515
    HGNC:8856
    6,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancer
    Les Laboratoires Servier
    07/21/26
    2D 3D TSV
  156. US12570607-B2
    133
    19
    P50750 Q00535 A0A090N7W4 Q00534 P11802 P24941 P50613 P06493
    HGNC:1780 1771 1778 1722 1777 1774 1773
    Compound as cyclin-dependent kinase 9 inhibitor and use thereof
    CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
    07/20/26
    2D 3D TSV
  157. US12570614-B2
    82
    44
    P52333 O60674 A0A024R7M7
    HGNC:6192 6193
    Phenyl amino pyrimidine compounds and uses thereof
    Glaxosmith Kline
    07/20/26
    2D 3D TSV
  158. US12570631-B2
    41
    41
    Q06187
    HGNC:1133
    Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk
    Biogen Ma
    07/20/26
    2D 3D TSV
  159. US12570646-B2
    74
    37
    Q13547 Q9UBN7
    HGNC:4852 14064
    Compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
    Chong Kun Dang Pharmaceutical
    07/20/26
    2D 3D TSV
  160. US12570659-B2
    307
    160
    P52333 A0A024R7M7 Q9NWZ3
    HGNC:6193 17967
    Bicyclic heteroaryl compounds useful as IRAK4 inhibitors
    Bristol Myers Squibb
    07/20/26
    2D 3D TSV
  161. US12570673-B2
    6
    6
    Q99417
    HGNC:7554
    c-Myc protein inhibitor, and preparation method therefor and use thereof
    Suzhou Kintor Pharmaceuticals
    07/20/26
    2D 3D TSV
  162. US12570675-B2
    404
    323
    P20618 P28074
    HGNC:9542 9537
    Boronic acid compounds
    LG Chem
    07/20/26
    2D 3D TSV
  163. US20260060961-A1
    41
    41
    P01116
    HGNC:6407
    SUBSTITUTED HETEROCYCLES AS RAS INHIBITORS
    Jazz Pharmaceuticals Ireland
    07/15/26
    2D 3D TSV
  164. US20260062376-A1
    52
    32
    P47746 P21554
    HGNC:2159
    SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS
    Research Triangle Institute
    07/15/26
    2D 3D TSV
  165. US20260062387-A1
    570
    190
    P57059 Q9H0K1 Q9Y2K2
    HGNC:29165 21680 11142
    SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
    Mitsubishi Tanabe Pharma
    07/15/26
    2D 3D TSV
  166. US20260062412-A1
    510
    437
    Q01538
    HGNC:7622
    NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY
    Chugai Seiyaku Kabushiki Kaisha
    07/15/26
    2D 3D TSV
  167. US20260062420-A1
    155
    87
    P97821 P53634
    HGNC:2528
    NOVEL DPP1 INHIBITORS AND USES THEREOF
    Insmed
    07/15/26
    2D 3D TSV
  168. US12565476-B2
    4
    4
    Q06124
    HGNC:9644
    2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
    Revolution Medicines
    07/13/26
    2D 3D TSV
  169. US12565480-B2
    15
    5
    P10635 P11712 Q6GRK0 P33261 P08684 P05177 P47989 C1ID52
    HGNC:2596 12805 2637 2625 2623 2621
    Thiophene derivatives as xanthine oxidase inhibitors and application thereof
    Tonghua Dongbao Pharmaceutical
    07/13/26
    2D 3D TSV
  170. US12565481-B2
    7
    1
    P10635 P11712 P07949 Q6GRK0 P33261 P08684 P05177 C1ID52
    HGNC:2596 2637 2625 2623 9967 2621
    6,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET
    Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory
    07/13/26
    2D 3D TSV
  171. US12565492-B2
    179
    161
    Q96SW2 Q16531 Q9UM73
    Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof
    Triana Biomedicines
    07/13/26
    2D 3D TSV
  172. US12565495-B2
    53
    33
    Q01827
    VMAT2 inhibitor and preparation method therefor and application thereof
    Luye Innomind Pharma Shijiazhuang
    07/13/26
    2D 3D TSV
  173. US12565497-B2
    120
    120
    P31153
    HGNC:6904
    Sulfone derivatives
    Hoffmann-La Roche
    07/13/26
    2D 3D TSV
  174. US12565500-B2
    4
    4
    Q06187
    HGNC:1133
    Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors
    Biogen Ma
    07/13/26
    2D 3D TSV
  175. US12565502-B2
    270
    31
    P50750 A0A090N7W4 P50613 P30285 P20248 Q00535 Q00534 P30281 O60563 P24941 P24864 P06493 Q00526 P25322 Q15078
    HGNC:3785 1771 1778 1722 1777 1774 3767 1775
    Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitors
    Pharmacosmos Holding
    07/13/26
    2D 3D TSV
  176. US12565504-B2
    100
    100
    O60502
    HGNC:7056
    Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
    Biogen Ma
    07/13/26
    2D 3D TSV
  177. US20260055088-A1
    24
    24
    Q9UQD0
    HGNC:10596
    HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF
    Jiangsu Hengrui Pharmaceuticals Co.
    07/09/26
    2D 3D TSV
  178. US20260055093-A1
    70
    51
    P97821 P53634
    HGNC:2528
    NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF
    Insmed
    07/09/26
    2D 3D TSV
  179. US20260055102-A1
    230
    115
    A0A024RCL1 Q16832 Q08345
    HGNC:2730 2731
    PYRIDO-PYRAZOLES AS INHIBITORS OF DDR'S FOR THE TREATMENT OF FIBROTIC DISORDERS AND CANCER
    Redx Pharma
    07/09/26
    2D 3D TSV
  180. US20260055104-A1
    8
    1
    A0A024R3T8 Q7Z3E1 Q9UGN5 Q9H2K2 Q460N5 O95271 Q460N3 Q2NL67 P09874
    HGNC:29232 270 11941 272 15677 26921 23696 26876
    CRYSTAL FORM OF HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOF
    Haisco Pharmaceutical Group Co.
    07/09/26
    2D 3D TSV
  181. US20260055107-A1
    6
    6
    P00751
    HGNC:1037
    SERIES OF NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUNDS AND PREPARATION METHOD THEREFOR
    CMS Research & Development
    07/09/26
    2D 3D TSV
  182. US20260055108-A1
    183
    183
    O00255
    HGNC:7010
    TRIAZINE COMPOUNDS AND USES THEREOF
    Hutchmed
    07/09/26
    2D 3D TSV
  183. US20260055113-A1
    17
    17
    P21589
    HGNC:8021
    HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER
    Hoffmann-La Roche
    07/09/26
    2D 3D TSV
  184. US20260055120-A1
    407
    87
    Q9HBY0 Q9NPH5 P04839 Q9Y5S8 Q96PH1
    HGNC:7889 7890 7891 2578 14874
    Bicyclic pyrimidinones as inhibitors of NOX4
    Boehringer Ingelheim International
    07/09/26
    2D 3D TSV
  185. US20260055126-A1
    64
    24
    Q15561 Q99594 P28347 Q15562
    HGNC:11716 11717 11714 11715
    SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF
    Hangzhou Phecdamed Co.
    07/09/26
    2D 3D TSV
  186. US20260055061-A1
    3
    3
    Q96SW2 Q15059
    HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION
    Department Of Health & Human Services
    07/08/26
    2D 3D TSV
  187. US20260055079-A1
    268
    209
    A0A024R3T8 Q7Z3E1 Q9UGN5 P09874
    HGNC:270 272 23696
    PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS
    Azkarra Therapeutics
    07/08/26
    2D 3D TSV
  188. US12558356-B2
    40
    40
    P62942
    HGNC:3711
    Immunophilin binding agents and uses thereof
    University Of California
    07/06/26
    2D 3D TSV
  189. US12559471-B2
    37
    19
    A0A090N8Q0 P28335 P28223 Q12809
    HGNC:6251 5295 5293
    1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof
    Jiangsu Nhwa Pharmaceutical Co.
    07/06/26
    2D 3D TSV
  190. US12559480-B2
    164
    156
    Q8NHG7
    HGNC:25238
    Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase
    University Of Pittsburgh
    07/06/26
    2D 3D TSV
  191. US12559487-B2
    27
    27
    A0A090N8Q0 Q12809
    HGNC:6251
    Crosslinked optically active secondary amine derivative
    Sumitomo Pharma Co.
    07/06/26
    2D 3D TSV
  192. US20260049068-A1
    88
    61
    P23743
    HGNC:2849
    Substituted Tetrazolyl Compounds Useful as T Cell Activators
    Bristol Myers Squibb
    07/01/26
    2D 3D TSV
  193. US20260049071-A1
    316
    110
    P35968 P17948 P35916 P00533
    HGNC:3763 6307 3767 3236
    PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF
    Beyang Therapeutics Co.
    07/01/26
    2D 3D TSV
  194. US20260049077-A1
    146
    59
    Q16288 P04629 Q16620
    HGNC:8031 8032 8033
    Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using Same
    Baylor College of Medicine
    07/01/26
    2D 3D TSV
  195. US20260049078-A1
    62
    31
    Q13547 Q9UBN7
    HGNC:4852 14064
    DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS
    Italfarmaco
    07/01/26
    2D 3D TSV
  196. US20260049082-A1
    24
    3
    P10635 P11712 Q6GRK0 P20813 P33261 P08684 P10632 P05177 C1ID52
    HGNC:2596 2637 2615 2625 2622 2623 2621
    AMIDO PYRIDO[3,4-B]INDOLE-1,4-DIONE COMPOUNDS FOR TREATMENT OF PORPHYRIAS
    Portal Therapeutics
    07/01/26
    2D 3D TSV
  197. US20260049084-A1
    218
    92
    O14638 P00915 P22413 P00918
    HGNC:1373 3356 1368 3358
    ENPP1 MODULATORS AND PRODUCTS AND USES THEREOF
    Gossamer Bio Services
    07/01/26
    2D 3D TSV
  198. US20260049089-A1
    18
    6
    P01116
    HGNC:6407
    KRAS INHIBITOR COMPOUND
    Shanghai Apeiron Therapeutics
    07/01/26
    2D 3D TSV
  199. US12552758-B2
    190
    95
    P54278 P40692
    HGNC:9122 7127
    Inhibitors of MLH1 and/or PMS2 for cancer treatment
    Neophore
    06/29/26
    2D 3D TSV
  200. US12552793-B2
    47
    47
    P78527
    HGNC:9413
    Purine derivative and medical use thereof
    Kangbaida (Sichuan) Biotechnology Co.
    06/29/26
    2D 3D TSV
  201. US12552795-B2
    85
    22
    P16234 P10635 P11712 Q6GRK0 P08684 P10721 C1ID52
    HGNC:8803 2637 6342 2625 2623
    Pyrrolotriazine derivatives for treating kit-and PDGFRA-mediated diseases
    Blueprint Medicines
    06/29/26
    2D 3D TSV
  202. US12552798-B2
    58
    25
    P00533 P51813 Q06187 Q08881
    HGNC:1079 1133 6171 3236
    Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitors
    Henan Zhiwei Biomedicine Co.
    06/29/26
    2D 3D TSV
  203. US12552799-B2
    76
    32
    P29274 P30542 P21554
    HGNC:262 263 2159
    Triazolone compounds
    Nxera Pharma
    06/29/26
    2D 3D TSV
  204. US12552811-B2
    9
    9
    Q15116 Q9NZQ7
    HGNC:8760
    Immunosuppressant, and preparation method therefor and use thereof
    Abbisko Therapeutics Co.
    06/29/26
    2D 3D TSV
  205. US20260042747-A1
    153
    153
    P10721
    HGNC:6342
    KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Alivexis
    06/26/26
    2D 3D TSV
  206. US20260042734-A1
    10
    10
    P22001
    HGNC:6221
    HETEROCYCLIC RING-SUBSTITUTED AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Shanghai Henlius Biotech
    06/24/26
    2D 3D TSV
  207. US20260042735-A1
    52
    23
    P31645 P19327 P28335 P34969 P28222 P28223 P41595 P46098 P28221 Q86XA9 P50406
    HGNC:5302 5301 5289 5287 5297 11050 5295 5294 5293 20276
    BENZYLTRYPTAMINE COMPOUNDS
    Reunion Neuroscience
    06/24/26
    2D 3D TSV
  208. US20260042752-A1
    179
    161
    Q96SW2 Q16531 Q9UM73
    ANAPLASTIC LYMPHOMA KINASE (ALK) DEGRADERS AND USES THEREOF
    Triana Biomedicines
    06/24/26
    2D 3D TSV
  209. US20260042753-A1
    234
    234

    INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
    Merck Patent
    06/24/26
    2D 3D TSV
  210. US20260042754-A1
    44
    44
    Q86W56
    HGNC:8605
    Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer
    Nodus Oncology
    06/24/26
    2D 3D TSV
  211. US20260042772-A1
    14
    7
    Q9UBF8 W7K9N9
    HGNC:8984
    FURO PYRIMIDINE DERIVATES
    Merck Patent
    06/24/26
    2D 3D TSV
  212. US20260042781-A1
    208
    104
    O60674
    HGNC:6192
    Bicyclic Ureas As Kinase Inhibitors
    Incyte
    06/24/26
    2D 3D TSV
  213. US12544359-B2
    37
    37
    C7C422
    1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors
    Infex Therapeutics
    06/22/26
    2D 3D TSV
  214. US12544374-B2
    151
    76
    Q15910 Q15022 O75530
    HGNC:1503
    AZA-quinoline compounds and uses thereof
    Novartis
    06/22/26
    2D 3D TSV
  215. US12544382-B2
    103
    103
    Q13535
    HGNC:882
    2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor
    Beijing Tide Pharmaceutical
    06/22/26
    2D 3D TSV
  216. US12545652-B2
    26
    3
    P52333 P29597 P10635 P11712 Q6GRK0 A0A024R7M7 P10632 C1ID52 O60674 P20813 P33261 P08684 P23458 P05177
    HGNC:2596 6190 6192 6193 2637 2615 2625 12440 2622 2623 2621
    Crystalline forms of a TYK2 inhibitor
    Sareum
    06/22/26
    2D 3D TSV
  217. US12545669-B2
    57
    52
    Q92794
    HGNC:13013
    Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives
    Pfizer
    06/22/26
    2D 3D TSV
  218. US12545672-B2
    71
    58
    O84106 B4RNM9
    Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof
    Debiopharm International
    06/22/26
    2D 3D TSV
  219. US12545673-B2
    170
    94
    Q02779 P80192 Q16584
    HGNC:6849 6861 6850
    Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient
    TSD Life Sciences
    06/22/26
    2D 3D TSV
  220. US20260034094-A1
    516
    515
    P48506
    HGNC:4311
    COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS
    Kojin Therapeutics
    06/18/26
    2D 3D TSV
  221. US20260034106-A1
    52
    52
    Q13451
    HGNC:3721
    Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics
    The Technical University of Darmstadt
    06/17/26
    2D 3D TSV
  222. US20260034113-A1
    30
    30
    O75417
    HGNC:9186
    THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOF
    Danatlas Pharmaceuticals
    06/17/26
    2D 3D TSV
  223. US20260034146-A1
    14
    14
    P14867
    HGNC:4075
    NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
    Washington University; Sage Therapeutics, Inc.
    06/17/26
    2D 3D TSV
  224. US20260034252-A1
    29
    29
    Q12884
    HGNC:3590
    FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF
    Ratio Therapeutics
    06/17/26
    2D 3D TSV
  225. US20260035340-A1
    101
    38
    P52895 P42330 P17516 Q04828
    HGNC:387 384 385 386
    INHIBITORS OF AKR1C3 AND METHODS OF USE
    University of Nebraska
    06/17/26
    2D 3D TSV
  226. US20260035341-A1
    181
    139
    P21964 Q9C0B1
    HGNC:2228 24678
    FTO INHIBITORS
    Rpxds
    06/17/26
    2D 3D TSV
  227. US20260035349-A1
    12
    12
    Q07343
    HGNC:8781
    3,4-alkoxy Substituted Phenethyl Lactam Compound, Preparation Method therefor, and Use Thereof
    Guangzhou Chia Tai Innovative Pharmaceutical
    06/17/26
    2D 3D TSV
  228. US20260035365-A1
    311
    152
    P00533
    HGNC:3236
    1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER
    Bayer Aktiengesellschaft; The Broad Institute, Inc.; Dana-Farber Cancer Institute, Inc.
    06/17/26
    2D 3D TSV
  229. US20260035382-A1
    295
    295
    Q9UBT2 Q9UBE0
    HGNC:2646
    COMPOUNDS AS SUMO ACTIVATING ENZYME INHIBITORS
    Wigen Biomedicine Technology (Shanghai)
    06/17/26
    2D 3D TSV
  230. US12540131-B2
    458
    456
    Q5S007
    HGNC:18618
    N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
    Merck Sharp & Dohme
    06/15/26
    2D 3D TSV
  231. US12540134-B2
    168
    132
    P18825
    HGNC:283
    Inhibitors of adrenoreceptor ADRAC2
    Bayer Aktiengesellschaft
    06/15/26
    2D 3D TSV
  232. US20260028365-A1
    812
    812
    P29597
    HGNC:12440
    TYROSINE KINASE 2 INHIBITORS AND USES THEREOF
    Biogen Ma
    06/12/26
    2D 3D TSV
  233. US20260027096-A1
    43
    43
    R4SCQ0 Q9GZT9
    HGNC:1232
    PHD INHIBITORS
    Oxford University Innovation
    06/10/26
    2D 3D TSV
  234. US20260027108-A1
    54
    47
    A0A024R3T8 Q7Z3E1 Q9UGN5 Q9H2K2 Q460N5 O95271 Q460N3 Q2NL67 P09874
    HGNC:29232 270 11941 272 15677 26921 23696 26876
    PHARMACEUTICAL COMPOSITION OF HETEROARYL DERIVATIVE AND MEDICAL USE THEREOF
    Haisco Pharmaceutical Group
    06/10/26
    2D 3D TSV
  235. US20260028321-A1
    48
    24
    Q13547 Q9UBN7
    HGNC:4852 14064
    1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND USES THEREOF
    Chong Kun Dang Pharmaceutical
    06/10/26
    2D 3D TSV
  236. US20260028326-A1
    283
    282
    Q96SW2
    HGNC:30185
    COMPOUND BASED ON ISOINDOLINE-SUBSTITUTED GLUTARIMIDE BACKBONE AND USE THEREOF
    Gluetacs Therapeutics (Shanghai)
    06/10/26
    2D 3D TSV
  237. US20260028327-A1
    19
    19
    Q6GRK0 P08684
    HGNC:2637
    KCC2 POTENTIATORS AND USES THEREOF
    Axonis Therapeutics
    06/10/26
    2D 3D TSV
  238. US20260028328-A1
    104
    52
    A0A024RCL1 Q16832 Q08345
    HGNC:2730 2731
    HETEROARYL DERIVATIVES AS DDRs INHIBITORS
    Chiesi Farmaceutici
    06/10/26
    2D 3D TSV
  239. US20260028334-A1
    105
    105
    P00338
    HGNC:6535
    N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER
    Wmt Aktiengesellschaft
    06/10/26
    2D 3D TSV
  240. US20260028337-A1
    50
    50
    Q9NWZ3
    HGNC:17967
    COMPOUND FOR INHIBITING IRAK4 ACTIVITY AND USE THEREOF
    Shenzhen Zhongge Biological Technology
    06/10/26
    2D 3D TSV
  241. US20260028352-A1
    186
    98
    P04629
    HGNC:8031
    MACROCYCLIC IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Suzhou Langrui Biopharmaceutical
    06/10/26
    2D 3D TSV
  242. US20260028354-A1
    207
    167
    Q96SW2 Q16531 P03372
    HGNC:2717 3467
    TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
    Regent Of The University Of Michigan
    06/10/26
    2D 3D TSV
  243. US20260028356-A1
    100
    48
    Q07817 P10415
    HGNC:992 990
    1,3,4,7-TETRAHYDRO-2H-PYRROLO[3',2':5,6]PYRIDO[2,3-B][1,4]OXAZEPINE BCL-2 INHIBITORS
    Abbvie
    06/10/26
    2D 3D TSV
  244. US12534425-B2
    5
    5
    P28223
    HGNC:5293
    Phenalkylamines and methods of treating mood disorders
    Gilgamesh Pharmaceuticals
    06/08/26
    2D 3D TSV
  245. US12534451-B2
    81
    81
    Q9H999
    HGNC:19365
    Small molecule modulators of PanK
    St. Jude Children''s Research Hospital, Inc.
    06/08/26
    2D 3D TSV
  246. US12534452-B2
    290
    289
    Q9NWZ3
    HGNC:17967
    N-(1H-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredient
    Kainos Medicine
    06/08/26
    2D 3D TSV
  247. US12534458-B2
    14
    14
    P36544
    HGNC:1960
    Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
    Merck Sharp & Dohme
    06/08/26
    2D 3D TSV
  248. US12534477-B2
    79
    54
    P10635 P11712 P50053 Q6GRK0 P33261 P08684 P05177 C1ID52
    HGNC:2596 2637 2625 2623 6315 2621
    Compound having KHK inhibitory effect
    Hangzhou Zhongmeihuadong Pharmaceutical
    06/08/26
    2D 3D TSV
  249. US20260021085-A1
    68
    46
    P54840 P13807 P46976
    HGNC:3023 21606
    CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
    Maze Therapeutics
    06/03/26
    2D 3D TSV
  250. US20260022100-A1
    19
    19
    Q9UQD0
    HGNC:10596
    NAV1.8 INHIBITOR
    Wuhan Humanwell Innovative Drug Research and Development Center
    06/03/26
    2D 3D TSV
  251. US20260022114-A1
    659
    633
    O75417 Q6GRK0 P08684
    HGNC:9186 2637
    N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USE
    Repare Therapeutics
    06/03/26
    2D 3D TSV
  252. US20260022118-A1
    76
    76
    P01111
    HGNC:7989
    HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS
    University of Texas System
    06/03/26
    2D 3D TSV
  253. US20260022122-A1
    64
    64
    P43490
    HGNC:30092
    NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME
    Checkmate Therapeutics
    06/03/26
    2D 3D TSV
  254. US20260022125-A1
    383
    383
    P35968
    HGNC:6307
    PYRROLOPYRIDAZINE VEGFR INHIBITORS
    Merck Sharp & Dohme
    06/03/26
    2D 3D TSV
  255. US20260022132-A1
    809
    360
    L7RSL8 Q07889 P01116
    HGNC:6407
    SPIROCYCLIC DIHYDROPYRANOPYRIMIDINE KRAS INHIBITORS
    Treeline Biosciences
    06/03/26
    2D 3D TSV
  256. US12527763-B2
    7
    7
    P08235
    HGNC:7979
    Pyrrole amide compound and use thereof
    Sunshine Lake Pharma
    06/01/26
    2D 3D TSV
  257. US12527774-B2
    192
    192
    P11474
    HGNC:3471
    Estrogen-related receptor alpha modulators
    Lead Pharma Holding
    06/01/26
    2D 3D TSV
  258. US12527775-B2
    296
    148
    P28335 P28223
    HGNC:5295 5293
    Heteroaromatic derivatives having serotonin receptor binding activity
    Shionogi
    06/01/26
    2D 3D TSV
  259. US12527776-B2
    23
    23
    Q13724
    HGNC:24862
    Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)
    Genzyme
    06/01/26
    2D 3D TSV
  260. US12527778-B2
    9
    9
    P00918
    HGNC:1373
    Enantiomers of a series of antiviral compounds
    Innovative Molecules
    06/01/26
    2D 3D TSV
  261. US12528773-B2
    82
    82
    Q5M868
    Non-lysosomal glucosylceramidase inhibitors and uses thereof
    Alectos Therapeutics
    06/01/26
    2D 3D TSV
  262. US12528797-B2
    27
    27
    Q96SW2 Q16531
    HGNC:2717
    Heterocyclic compounds for medical treatment
    C4 Therapeutics
    06/01/26
    2D 3D TSV
  263. US12528814-B2
    262
    192
    Q9NWZ3
    HGNC:17967
    Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof
    Nurix Therapeutics
    06/01/26
    2D 3D TSV
  264. US20260015341-A1
    38
    38
    O00329 P48736 P42338 P42336
    HGNC:4498
    PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Hinova Pharmaceuticals
    05/29/26
    2D 3D TSV
  265. US20260015351-A1
    21
    19
    O14733
    HGNC:6847
    METHODS AND COMPOUNDS FOR INHIBITING MKK7 ENZYMES
    Axonis Therapeutics
    05/29/26
    2D 3D TSV
  266. US20260015358-A1
    340
    340
    Q14191
    HGNC:12791
    BICYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF
    Danatlas Pharmaceuticals
    05/29/26
    2D 3D TSV
  267. US20260015372-A1
    16
    15
    Q04844 P06276
    HGNC:983 1966
    Organophosphorous Compounds and Uses Thereof
    Jal Therapeutics
    05/29/26
    2D 3D TSV
  268. US20260014125-A1
    107
    106
    P31153
    HGNC:6904
    BICYCLIC-TYPE MAT2A INHIBITOR AND USE THEREOF
    Haihe Biopharma
    05/28/26
    2D 3D TSV
  269. US20260014133-A1
    65
    65
    Q96SW2 Q16531
    HGNC:2717
    SUBSTITUTED 3-(l-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE/2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-l,3-DIONE ANALOGS AS MODULATORS OF CEREBLON PROTEIN
    St. Jude''s Chidren''s Research Hospital, Inc.
    05/28/26
    2D 3D TSV
  270. US20260014146-A1
    52
    51
    P24941 P24864
    HGNC:1771
    CDK2 INHIBITORS AND METHODS OF USING THE SAME
    Cedilla Therapeutics
    05/28/26
    2D 3D TSV
  271. US20260014174-A1
    8
    4
    P03366 O15379
    HGNC:4854
    DUAL INHIBITORS FOR HDAC3 AND HIV-1 PR
    Purdue Research Foundation
    05/28/26
    2D 3D TSV
  272. US20260015328-A1
    121
    109
    A0A024R3C7 Q13315
    HGNC:795
    ATM KINASE INHIBITORS
    Eberhard Karls University of TuBingen
    05/28/26
    2D 3D TSV
  273. US20260015340-A1
    6
    3
    Q92918 Q16584
    HGNC:6850 6863
    COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
    Korea Research Institute of Chemical Technology
    05/28/26
    2D 3D TSV
  274. US12521375-B2
    30
    15
    Q13085 O00763
    HGNC:85 84
    Pharmaceutical composition for treating fatty liver disease
    Shionogi
    05/26/26
    2D 3D TSV
  275. US12522579-B2
    18
    6
    P10636 P21397 P27338
    HGNC:6833 6834 6893
    Monoamine oxidase B imaging probe
    Tohoku University
    05/26/26
    2D 3D TSV
  276. US12522582-B2
    28
    18
    P00915 P00918
    HGNC:1373 1368
    Antiviral indolinyl compounds and uses thereof
    Gilead Sciences
    05/26/26
    2D 3D TSV
  277. US12522583-B2
    22
    22
    O60674
    HGNC:6192
    Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof
    Dana-Farber Cancer Institute
    05/26/26
    2D 3D TSV
  278. US12522584-B2
    14
    14
    O14744
    HGNC:10894
    3,4-dihydroisoquinoline compound and use thereof
    CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
    05/26/26
    2D 3D TSV
  279. US12522593-B2
    105
    105
    P53634
    HGNC:2528
    Azacycloalkyl carbonyl cyclic amine compound
    Alivexis
    05/26/26
    2D 3D TSV
  280. US12522602-B2
    411
    411
    Q13724
    HGNC:24862
    Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same
    Yuhan
    05/26/26
    2D 3D TSV
  281. US12522603-B2
    186
    182
    Q13724 Q8N884
    HGNC:24862 21367
    Inhibitors of gas for treating autoinflammatory diseases and cancer metastasis
    The Rockefeller University; Memorial Sloan-Kettering Cancer Center
    05/26/26
    2D 3D TSV
  282. US12522615-B2
    18
    6
    P00533
    HGNC:3236
    Macrocyclic compounds and derivatives as EGFR inhibitors
    Boehringer Ingelheim International
    05/26/26
    2D 3D TSV
  283. US12522616-B2
    13
    13
    P28482
    HGNC:6871
    Thiazololactam compound as ERK inhibitor and use thereof
    D3 Bio (Wuxi)
    05/26/26
    2D 3D TSV
  284. US12522634-B2
    26
    13
    P23284 P62937 V9HWF5
    HGNC:9253 9255
    Cyclophilin inhibitors and uses thereof
    Farsight Medical Technology (Shanghai)
    05/26/26
    2D 3D TSV
  285. US20260007787-A1
    123
    123
    Q12884
    HGNC:3590
    RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORS
    Trustees of Tufts College
    05/21/26
    2D 3D TSV
  286. US20260008750-A1
    5
    5
    B4EYG0 B4EYG1
    HGNC:5286
    COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
    The Cleveland Clinic Foundation
    05/21/26
    2D 3D TSV
  287. US20260008758-A1
    178
    140
    P97821 P53634
    HGNC:2528
    LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF
    Insmed
    05/21/26
    2D 3D TSV
  288. US20260008770-A1
    122
    122
    Q13191
    HGNC:1542
    CBL-B INHIBITORS AND METHODS OF USES THEREOF
    Insilico Medicine IP
    05/21/26
    2D 3D TSV
  289. US20260008771-A1
    12
    12
    P41595
    HGNC:5294
    PYRIDAZINE BASED SMALL MOLECULE INHIBITOR OF COGNITIVE IMPAIRMENT
    Columbia University
    05/21/26
    2D 3D TSV
  290. US20260008775-A1
    182
    181
    A0A024R5F7 Q9UBM7
    HGNC:2860
    AZOLE MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION
    Genentech
    05/21/26
    2D 3D TSV
  291. US20260007675-A1
    12
    12
    O00255 Q03164
    HGNC:7010
    TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA
    Memorial Sloan Kettering Cancer Center
    05/20/26
    2D 3D TSV
  292. US20260007681-A1
    84
    70
    Q96SW2 Q16531 P03372
    HGNC:2717 3467
    INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
    University Of Michigan
    05/20/26
    2D 3D TSV
  293. US20260007684-A1
    337
    326
    Q96P20
    HGNC:16400
    AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
    Ventus Therapeutics U.
    05/20/26
    2D 3D TSV
  294. US12516046-B2
    133
    131
    Q9UQD0
    HGNC:10596
    2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
    Merck Sharp & Dohme
    05/19/26
    2D 3D TSV
  295. US12514858-B2
    65
    65
    P28907
    HGNC:1667
    CD38 inhibitors
    Astellas Engineered Small Molecules US
    05/18/26
    2D 3D TSV
  296. US12516038-B2
    253
    253
    O77963
    Inhibitors of antigen presentation by HLA-DR
    Janssen Pharmaceutica
    05/18/26
    2D 3D TSV
  297. US12516054-B2
    3
    3
    P07949
    HGNC:9967
    Pyrazolo[1,5-a]pyridine derivatives, preparation method therefor and use thereof
    Shanghai Daidai Investment Consulting
    05/18/26
    2D 3D TSV
  298. US20260001898-A1
    6
    1
    P52333 P29597 O60674 P23458
    HGNC:6190 6192 6193 12440
    Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof
    Accro Bioscience (Hk)
    05/14/26
    2D 3D TSV
  299. US20260000676-A1
    207
    163
    Q96SW2 Q16531 P11474
    HGNC:3471 2717
    CHROMAN DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
    University Of Michigan
    05/13/26
    2D 3D TSV
  300. US20260001833-A1
    5
    5
    A0AAJ0YC41
    COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE
    The Cleveland Clinic Foundation
    05/13/26
    2D 3D TSV
  301. US20260001863-A1
    36
    36
    Q13822 Q9HBW0
    NOVEL PYRIDAZINES
    Boehringer Ingelheim International
    05/13/26
    2D 3D TSV
  302. US20260001864-A1
    111
    111
    P20648
    HGNC:819
    COMPOUND CONTAINING SULFAMIDE STRUCTURE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION
    Nanjing Shuohui Pharmatechnology
    05/13/26
    2D 3D TSV
  303. US20260001868-A1
    4
    2
    O14744 Q9BQA1
    HGNC:29652
    HETEROCYCLIC COMPOUND CAPABLE OF INHIBITING PRMT5-MTA AND USE THEREOF
    Xizang Haisco Pharmaceutical
    05/13/26
    2D 3D TSV
  304. US20260001879-A1
    225
    209
    Q01538
    HGNC:7622
    COMPOUNDS AS MYT1 INHIBITORS
    Wigen Biommedicine Technology (Shanghai)
    05/13/26
    2D 3D TSV
  305. US20260001881-A1
    36
    12
    P29274 P0DMS8 P30542
    HGNC:268 262 263
    COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORS
    Primetime Life Sciences
    05/13/26
    2D 3D TSV
  306. US20260001884-A1
    3
    3
    P21589
    HGNC:8021
    Heterocycle compounds for the treatment of cancer
    Hoffmann-La Roche
    05/13/26
    2D 3D TSV
  307. US20260001886-A1
    266
    86
    P00915 P22413 P00918
    HGNC:1373 3356 1368
    ENPP1 INHIBITORS I
    RE Ventures I
    05/13/26
    2D 3D TSV
  308. US20260001887-A1
    40
    20
    P11802 P06493
    HGNC:1722 1773
    CYCLIN-DEPENDENT KINASE INHIBITORS
    Novartis
    05/13/26
    2D 3D TSV
  309. US20260001888-A1
    90
    90
    O76083
    HGNC:8795
    PYRAZOLOPYRIMIDINE PDE9 INHIBITORS
    Merck Sharp & Dohme
    05/13/26
    2D 3D TSV
  310. US20260001892-A1
    80
    80
    P15428
    HGNC:5154
    COMPOUND FOR REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH AND PREPARATION METHOD THEREFOR
    Scinnohub Pharmaceutical
    05/13/26
    2D 3D TSV
* for human-derived proteins